603676.SS · 卫信康
China A-shares · RS rating 55 · As of 2026-10-14
| Price | 8.93 CNY |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 55 / 73 / 58 / 33 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 23 / 28 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -18.6% |
| Distance from 52-week high | +25.6% |
| Market cap (USD) | $589.0M |